/

Società

Co

Non verificato

Confo Therapeutics

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

2 comunicati stampa

Guarda tutti i comunicati

01/10/2024

Industria

Salute

Medicina - Varie

Scienza

Farmaceutica

Biotecnologia

Confo Therapeutics Announces Publication in Nature Communications Demonstrating First-Ever Structure of a Complex Between an Antibody-based Agonist and a Class A GPCR Regulating Hunger and Satiety

Fonte

Confo Therapeutics

Emittente

1.00

0

26/07/2024

Scienza

Biotecnologia

Farmaceutica

Salute

Medicina - Varie

Sanità

Confo Therapeutics Announces EUR 60M Series B Financing to Advance Pipeline of Novel GPCR-Modulating Therapies into Clinical Development

Fonte

Confo Therapeutics

Emittente

1.00

0

Seguaci

0

Compatibilità

0